How to Effectively Manage Government and Internal Investigations During COVID-19
While technology makes remote investigations manageable, there are key flexibility and best-practice considerations to assist companies in preserving investigative integrity, confidentiality, and independence throughout the crisis.
May 11, 2020 at 12:55 PM
8 minute read
Since the outbreak of COVID-19, many U.S. agencies have stated that current investigations will proceed, and the government will commence new inquiries. Indeed, this is not a time for companies to let down their guard. Because most companies are operating remotely, they should be prepared, as the government is, to leverage technology as a substitute for typical in-person investigation-related activities. While technology makes remote investigations manageable, there are key flexibility and best-practice considerations to assist companies in preserving investigative integrity, confidentiality, and independence throughout the crisis.
Investigative Agency Responses to COVID-19
The COVID-19 pandemic has had a unique impact on U.S. agencies. The Federal Bureau of Investigation (FBI), while operating primarily within a remote platform, is functioning more or less normally. Others are de-prioritizing investigations unrelated to the current health crisis, as employees and resources are redirected at an unprecedented level. Further, agencies led by more explicitly political actors, such as state attorney general offices, are likely to shift their near term focus to matters related to COVID-19. The same is true for agencies that include healthcare issues as part of their regular investigative portfolio.
The U.S. Department of Justice (DOJ) recently asked Congress for certain temporary emergency powers during the pandemic, including the ability to delay court proceedings, toll statutes of limitations, and expand the use of videoconferencing. The full extent to which Congress is receptive to such requests remains to be seen, but this highlights the realities facing many agencies. The DOJ is also prioritizing misconduct allegations related to COVID-19, including fraud, price gouging and hoarding of critical supplies.
The Securities and Exchange Commission (SEC) has extended various filing deadlines, but is encouraging companies to be proactive and consider the need for COVID-19-related disclosures within the context of federal securities laws and the SEC's principles-based disclosure system. The SEC emphasized that it is only with exposure to such disclosures that investors can make informed decisions. The SEC also reminded corporations of the importance of refraining from trading on the basis of material, nonpublic information.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250